What is the role of hyperbaric oxygen in the... (2012 study) Skip to main content
RCT Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2012

What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.

Freiberger JJ, Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, et al., Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers compared two groups of patients with bisphosphonate-related osteonecrosis of the jaw: one got hyperbaric oxygen added to surgery and antibiotics, and the other got surgery and antibiotics alone.

What They Found

In this randomized controlled trial of 46 patients with bisphosphonate-related osteonecrosis of the jaw, 17 of 25 patients given hyperbaric oxygen (68%) improved versus 8 of 21 controls (38.1%), with a p-value of 0.043. The oxygen was given at 2 atm twice a day for 40 treatments, and patients were followed for 24 months. Mean time to improvement was 39.7 weeks with hyperbaric oxygen versus 67.9 weeks for controls (p-value 0.03). Complete gum healing did not differ significantly: 14 of 25 (52%) versus 7 of 21 (33.3%), with a p-value of 0.203. Time to healing was also not significantly different (p-value 0.32). Pain decreased faster in the hyperbaric oxygen group, and physical health and perceived health quality-of-life scores fell at 6 months in the control group but not in the hyperbaric oxygen group.

What This Means for Canadian Patients

For people with jaw osteonecrosis linked to bisphosphonate drugs, this trial found more patients improved and pain eased faster when hyperbaric oxygen was added to surgery and antibiotics. It did not find a significant difference in complete gum healing. The authors say hyperbaric oxygen appears to be a useful add-on, but that the study was underpowered to fully support this.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The authors state the study was underpowered to fully support its conclusion, and the differences in complete gum healing and time to healing were not statistically significant.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Wound Care
Source Pubmed
PubMed ID 22698292
Year Published 2012
Journal Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
MeSH Terms Aged; Alendronate; Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Breast Neoplasms; Combined Modality Therapy; Debridement; Diphosphonates; Female; Follow-Up Studies; Gingiva; Humans; Hyperbaric Oxygenation; Imidazoles

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology